Semaglutide for Weight Loss with Diabetes

Last reviewed: June 7, 2026

Last updated: June 7, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

People with type 2 diabetes who take semaglutide often experience meaningful weight loss while their blood sugar levels improve. Unlike older diabetes medications that can cause weight gain, semaglutide works through a different pathway in the brain and pancreas that naturally suppresses hunger and slows digestion. Clinical trials show that people taking semaglutide lose an average of 10–15% of body weight over one year while also reducing their diabetes complications.

How Semaglutide Addresses Both Diabetes and Weight

Semaglutide mimics a hormone called glucagon-like peptide 1 (GLP-1) that your body makes naturally after eating. When you inject semaglutide, it signals your pancreas to release insulin when blood sugar rises, helping prevent the blood sugar spikes that happen in type 2 diabetes. At the same time, it tells your brain that your stomach is fuller than it actually is, which reduces hunger and makes eating smaller portions feel normal.

The dual action—better blood sugar control plus reduced appetite—creates an advantage that single-action diabetes drugs cannot match. People with diabetes who use semaglutide often report needing less insulin or fewer other diabetes medications over time, and their A1C (average blood sugar over three months) typically drops by 1–2 percentage points. The weight loss reinforces better blood sugar control because carrying less body weight makes insulin work more efficiently in your cells.

Clinical Evidence: Semaglutide Weight Loss Results in Diabetes Patients

The SUSTAIN trial series, which studied semaglutide in people with type 2 diabetes, showed that participants lost 4–8 pounds over 30 weeks on standard doses. However, when semaglutide is prescribed specifically for weight loss (at higher doses than traditional diabetes dosing), the STEP trials documented average weight loss of 15–22% of body weight over 68 weeks. People with diabetes enrolled in those trials lost weight at similar rates to people without diabetes, proving that the medication works equally well regardless of diabetes status.

Beyond weight numbers, semaglutide reduces heart attacks, strokes, and kidney damage in people with diabetes—benefits that come from both improved blood sugar control and weight loss itself. Studies also show that semaglutide improves inflammation markers and blood pressure, additional factors that contribute to better long-term health outcomes. The cardiovascular and metabolic improvements often appear within the first three months of treatment.

Starting Semaglutide: Dosing and Timeline for People with Diabetes

Semaglutide treatment begins at a low dose (usually 0.25 mg per week) to let your body adjust and minimize side effects. The dose increases gradually every four weeks until reaching your optimal level, which may range from 0.5 mg to 2.4 mg per week depending on your response and diabetes medication needs. Your dose may need to go up. Your price won't—PlexusDx charges a flat monthly rate regardless of which dose you use, because the goal is sustainable treatment without financial barriers.

Most people experience noticeable appetite reduction and early weight loss within the first two to four weeks. Your diabetes medications may need adjustment within the first month because your blood sugar will improve faster than expected, reducing your risk of dangerously low blood sugar (hypoglycemia). PlexusDx works with your doctor to monitor your blood sugar logs and adjust diabetes medications in parallel with semaglutide increases.

Side Effects and Safety When Using Semaglutide with Diabetes

The most common side effects are nausea, vomiting, constipation, and diarrhea, which affect 20–40% of users and typically fade within two to four weeks as your body adjusts. Because semaglutide slows stomach emptying, these gastrointestinal effects are usually mild when you start at the low dose and increase slowly. Serious side effects like pancreatitis or severe allergic reactions are very rare (less than 1% of users).

People with diabetes taking semaglutide must monitor blood sugar carefully, especially if they also take insulin or sulfonylureas, because semaglutide increases insulin sensitivity and can cause low blood sugar if other medications aren't reduced. Your prescribing doctor reviews your diabetes regimen before starting semaglutide and adjusts it proactively. PlexusDx compounded semaglutide is supplied by licensed 503A pharmacies and includes detailed patient education on recognizing and preventing hypoglycemia.

Understanding Your Genetic Response to Semaglutide

Not everyone responds to semaglutide identically—some people lose 20% of their body weight while others lose 8%, even at the same dose. Genetic variations in your GLP-1 receptor gene, your FTO gene (which influences hunger signals), and other peptide pathways influence how strongly you respond to semaglutide. The PlexusDx Precision Peptide Genetic Test identifies your genetic predispositions across 14 metabolic pathways and 49 peptides, helping predict which medication (semaglutide, tirzepatide, or a combination) and which dose range will work best for your unique biology.

For example, people with certain variants in the GLP1R gene may experience stronger appetite suppression at lower doses, while others with FTO variants may benefit from combination therapy with tirzepatide. Understanding your genetics before starting treatment removes guesswork and increases the likelihood of meaningful weight loss and diabetes improvement. The Precision Peptide Genetic Test is available as a $99 add-on after your first month of treatment.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Can semaglutide help me lose weight if I have type 2 diabetes?

Yes. Semaglutide improves blood sugar control while suppressing appetite, leading to weight loss of 10–15% on average in people with type 2 diabetes. PlexusDx offers compounded semaglutide injections starting at $149/month, with no insurance required and no membership fees.

Will semaglutide allow me to reduce my other diabetes medications?

Often yes. Semaglutide improves insulin sensitivity, so many people need less insulin or fewer other diabetes drugs within the first month. Your doctor monitors your blood sugar and adjusts your diabetes regimen in parallel with semaglutide dosing to prevent low blood sugar.

How much weight can I realistically lose on semaglutide with diabetes?

Clinical trials show average weight loss of 10–15% of body weight over one year in people with type 2 diabetes. Some people lose more, especially when combining semaglutide with lifestyle changes; individual results vary based on genetics, starting weight, and adherence.

What side effects should I expect, and how long do they last?

Nausea, vomiting, and constipation are most common and affect 20–40% of users. These typically fade within two to four weeks as your body adjusts. Starting at a low dose and increasing gradually minimizes side effects and helps you tolerate the medication long-term.

Can genetic testing help me know if semaglutide will work for me?

Yes. The PlexusDx Precision Peptide Genetic Test ($99 after your first month) analyzes 14 metabolic pathways and 150+ genetic insights, including your GLP1R and FTO variants, to predict your likely response and recommend semaglutide, tirzepatide, or combination therapy.

Is PlexusDx semaglutide FDA-approved?

PlexusDx semaglutide is compounded by licensed 503A pharmacies using FDA-approved active ingredients. Compounded medications are not FDA-approved as finished products but are regulated by state pharmacy boards and comply with USP standards for quality and sterility.

Does Ozempic Work for Weight Loss If You Have Diabetes?